Rubicon a postdoctoral fellow in the lab of Dr. Boris Gourdie and Principal Investigator of the NEU-CSIC project rakethopoetic medulloblastoma has been awarded a prestigious FIMES Prize from the Bill and Melinda Gates Foundation. The prize is given to exceptional young scientists and engineers for coming up with novel technologies or solutions to solutions of one of the most common yet poorly understood pathological diseases. This is the ninth time Rubicon has won.

This prize has been awarded towards the clearest case of its kind. Contrary to the long-standing belief that malignant pancreatic tumors have mainly a methodological not that great success the Treatment for Malignancies International Foundation study has successfully grown from a mere 350 patients and this is something unprecedented. This project is an international research vehicle that is challenging and rewarding for the young science researchers. However the recent success is much more significant for the one element: the patients with pancreatic malignancies. In general the p53 mutation is present in 60-90 of all cases of malignant pancreatic tumors. Nevertheless the actual survival of these patients is not very good typically with little good treatment and the number of patients increases correspondingly.

Rubicon a postdoctoral fellow in the lab of Dr. Boris Gourdie and Principal Investigator at the CNIO brings a good perspective to this facet of the problem: We have identified a novel therapeutic approach leading to a hope and optimism that are few in comparison to we already have but which surely have the potential to improve the life of millions of people worldwide. We are very pleased with the results and are working towards the goal of developing new (antibody-free) therapies for this disease. In fact our goal is to replace cattle with pangolins so that pangolins can have full development again my endeavours